Acist Medical System is the world leader in the production of contrast systems for angiography. It was the company Acist Medical Systems that introduced the concept of "variable flow" into the process of X-ray endovascular interventions, which allowed replacing the manual introduction of contrast in coronary angiography, using an automatic injector. This made coronary angiography much safer and more effective, allowed to reduce the dose of contrast administered and, as a consequence, reduced the likelihood of development of contrast-induced nephropathy.
The company Acist Medical Systems was founded in 1991 and now more than 10 million procedures are performed worldwide with the help of Acist CVi inverters.
The contrast injector with Variable Flow Technology ACIST CVi® is an intelligent device that simplifies the introduction of contrast when performing all interventional interventions and diagnostic manipulations.